At the latest Strategic Advisory Group of Experts (SAGE) on Immunization meeting, the working group discussed an extensive review of the evidence of BCG vaccine use for protection against mycobacterial… Click to show full abstract
At the latest Strategic Advisory Group of Experts (SAGE) on Immunization meeting, the working group discussed an extensive review of the evidence of BCG vaccine use for protection against mycobacterial infections including tuberculosis, leprosy, and other nontuberculous mycobacteria infections. We fear that these policy recommendations will not translate into the warranted changes in implementation unless they are accompanied by appropriate indicators. In this commentary, we suggest that BCG coverage should be reported as both coverage at 1 month and 12 months.
               
Click one of the above tabs to view related content.